gatifloxacin has been researched along with Age-Related Macular Degeneration in 1 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorrepaal, SJ | 1 |
| Gale, J | 1 |
| El-Defrawy, S | 1 |
| Sharma, S | 1 |
1 other study available for gatifloxacin and Age-Related Macular Degeneration
| Article | Year |
|---|---|
Resistance of ocular flora to gatifloxacin in patients undergoing intravitreal injections.
Topics: Administration, Topical; Aged; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibodies, Monoclona | 2014 |